Table 4.
Compound | HL-60 | HL-60/vinc | LoVo | LoVo/DX | ||
---|---|---|---|---|---|---|
SI | SI | IR | SI | SI | IR | |
SAL | 39.45 | 5.59 | 7.06 | 27.70 | 16.07 | 1.72 |
F-o | 1.64 | 1.34 | 1.22 | 1.71 | 2.57 | 0.66 |
F-m | 0.10 | - | - | 0.48 | 1.65 | 0.29 |
F-p | 2.40 | 0.73 | 3.28 | 1.40 | 2.62 | 0.53 |
Cl-o | 1.89 | 1.50 | 1.25 | 1.56 | 2.06 | 0.76 |
Cl-m | 4.52 | 2.63 | 1.72 | 1.49 | 5.86 | 0.25 |
Cl-p | 0.21 | 0.16 | 1.29 | 0.40 | 0.46 | 0.86 |
Br-o | 2.08 | 1.36 | 1.53 | 1.79 | 2.27 | 0.79 |
Br-m | 2.74 | 1.31 | 2.09 | 1.77 | 2.73 | 0.65 |
Br-p | 0.41 | 0.25 | 1.62 | 0.52 | 1.69 | 0.30 |
NO2-o | 2.75 | 1.40 | 1.97 | 2.51 | 3.90 | 0.64 |
NO2-m | 2.84 | 1.01 | 2.80 | 1.54 | 7.64 | 0.20 |
NO2-p | - | - | - | 0.52 | 0.34 | 1.53 |
doxorubicin | 4.50 | 0.20 | 22.00 | 1.20 | 0.03 | 36.40 |
cisplatin | 5.30 | 0.77 | 6.87 | 1.43 | 1.02 | 1.41 |
The IR and SI values were calculated for each compounds using formula: RI = IC50 for drug-resistant cell line/IC50 for appropriate drug-sensitive cell line; SI = IC50 for normal cell line (BALB/3T3)/IC50 for respective cancerous cell line.